GLP-1s are serious medications with certain potential toxicities for some patients, including pancreatitis, thyroid cancer, and very rarely, but now officially acknowledged in the case of Wegovy blindness, caused by a condition called non-arteritic anterior ischemic optic neuropathy (NAION)
Tewari and Jefferies are projecting peak-year sales of $25 billion for orforglipronabout double the DKK 120.342 billion ($18.84 billion) generated by Ozempic last year, and more than double the $11.54 billion racked up by Lillys tirzepatide as a type 2 diabetes drug marketed as Mounjaro
Glucagon-like peptide-1 (GLP-1) is a hormone produced by the body which aids in insulin production and blood sugar regulation
Why Lab Work Is Not Optional on GLP-1 Therapy Before getting into the questions themselves, some context is useful
Symptoms include tingling, burning, or unusual pain on touch
Neurobiological effects of the green tea constituent theanine and its potential role in the treatment of psychiatric and neurodegenerative disorders